LONDON--(BUSINESS WIRE)--LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, today announced that Japan’s Ministry of Health, Labour and Welfare granted national reimbursement for ...
LONDON--(BUSINESS WIRE)--LivaNova PLC (NASDAQ:LIVN) (“LivaNova” or the “Company”), a market-leading medical technology company, has announced the first patient enrollment in the Perceval ® Valve ...
LONDON, LivaNova, PLC (NASDAQ:LIVN) (“LivaNova” or the “Company”), a market-leading medical technology and innovation company, announced the presentation of data from multiple studies demonstrating ...
The next-generation sutureless surgical technology is based on a clinically proven platform and designed for valve durability Perceval Plus is the next generation of Perceval, which is a trusted ...
PERSIST-AVR study results presented at American Association for Thoracic Surgery Annual Meeting PERSIST-AVR is the first prospective, randomized, multi-center international trial comparing Perceval ...
LONDON--(BUSINESS WIRE)-- LivaNova PLC (NASDAQ:LIVN) (“LivaNova” or the “Company”), a market-leading medical technology company, today announced its Perceval ® sutureless aortic heart valve received ...
LivaNova delivered new data from its sutureless aortic heart valve, showing fewer complications and stronger clinical outcomes compared to traditional implants built on a stent frame. An international ...
But again, we are going to focus on going deep rather than going wide with Perceval. And the last thing I want to say is that again early days in the U.S. but we have a long term for Perceval which is ...
LONDON, LivaNova, PLC, a global medical technology company and a leader in the treatment of cardiovascular diseases, announced the first U.S. implantation of the Perceval valve, the sutureless ...
The companies have teamed to develop an alternative to TAVR that combines the benefits of a less-invasive procedure with the ...
LONDON, August 25, 2025--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced it will host an Investor Day and product showcase on Wed., Nov. 12, ...
LivaNova reported mixed Q1/2017 results. Revenues slightly missed while EPS beat, thanks to a good cost control in R&D and SG&A expenses. With the stock up 40% since late 2016, there could be some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback